UK SMEs subject to new R&D tax relief status interpretation
This article was originally published in Clinica
Executive Summary
UK small and medium-sized enterprises (SMEs) applying for tax relief under Revenue & Customs' (HMRC) research and development (R&D) scheme and which lose their SME status through changes such as a merger or takeover are now treated as large companies for the entire accounting period. Prior to December 1 2008, from which date such changes take effect, SMEs had been able to retain their status throughout the accounting period.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.